# The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

> **NCT05741944** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Soft-tissue Sarcoma
- Predictive Cancer Model

## Interventions

- **OTHER:** Care with the use of PERSARC
- **OTHER:** standard care

## Key facts

- **NCT ID:** NCT05741944
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-24
- **Primary completion:** 2024-08-29
- **Final completion:** 2025-08-29
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741944, "The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05741944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*